These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 17642201)

  • 1. [Combined therapy with L-carnitine and erythropoietin of anemia in chronic kidney failure patients undergoing hemodialysis].
    Wanic-Kossowska M; Kazmierski M; Pawliczak E; Kobelski M
    Pol Arch Med Wewn; 2007; 117(1-2):14-9. PubMed ID: 17642201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anemia and carnitine supplementation in hemodialyzed patients.
    Kletzmayr J; Mayer G; Legenstein E; Heinz-Peer G; Leitha T; Hörl WH; Kovarik J
    Kidney Int Suppl; 1999 Mar; 69():S93-106. PubMed ID: 10084293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis].
    Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F
    Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
    Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma carnitine profile during chronic renal anemia treatment with recombinant human erythropoietin.
    Debska-Slizień A; Owczarzak A; Kunicka D; Lysiak-Szydłowska W; Rutkowski B
    Int J Artif Organs; 2003 Jan; 26(1):33-8. PubMed ID: 12602467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with darbepoietin alfa (NESP) in children undergoing hemodialysis.
    De Palo T; Giordano M; Palumbo F; Bellantuono R; Messina G; Colella V; Caringella AD
    Pediatr Nephrol; 2004 Mar; 19(3):337-40. PubMed ID: 14745634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
    Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
    Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of erythropoietin beta, two to three times per week, once per week and once every other week: meta-analysis of two clinical trials].
    Pljesa S
    Med Pregl; 2007; 60(3-4):123-7. PubMed ID: 17853722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients.
    Matsumura M; Hatakeyama S; Koni I; Mabuchi H; Muramoto H
    Nephron; 1996; 72(4):574-8. PubMed ID: 8730424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recombinant human erythropoietin: 18 months of continuous use in substitution hemodialysis].
    Canaud B; Polito-Bouloux C; Rivory JP; Donnadieu P; Taib J; Florence P; Mion C
    Nephrologie; 1990; 11(1):5-10. PubMed ID: 2374643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemia Evaluation and Erythropoietin Dose Requirement Among Hemodialysis Patients: a Multicenter Study.
    Nafar M; Samavat S; Khoshdel A; Alipour-Abedi B
    Iran J Kidney Dis; 2017 Jan; 11(1):56-65. PubMed ID: 28174354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of oral L-carnitine therapy in chronic hemodialysis patients.
    Sabry AA
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):454-9. PubMed ID: 20427868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-carnitine supplementation and EPO requirement in children on chronic hemodialysis.
    Aoun B; Bérard E; Vitkevic R; Dehée A; Bensman A; Ulinski T
    Pediatr Nephrol; 2010 Mar; 25(3):557-60. PubMed ID: 19662438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anemia of chronic renal failure: treatment with erythropoietin.
    Navarro M; Alonso A; Avilla JM; Espinosa L
    Child Nephrol Urol; 1991; 11(3):146-51. PubMed ID: 1777893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of L-carnitine supplementation on renal anemia in poor responders to erythropoietin.
    Matsumoto Y; Amano I; Hirose S; Tsuruta Y; Hara S; Murata M; Imai T
    Blood Purif; 2001; 19(1):24-32. PubMed ID: 11114574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
    Dimković N
    Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of model predictive control for improved anemia management.
    Brier ME; Gaweda AE; Dailey A; Aronoff GR; Jacobs AA
    Clin J Am Soc Nephrol; 2010 May; 5(5):814-20. PubMed ID: 20185598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemoglobin response and influence on left ventricular hypertrophy after 24-week treatment of a biosimilar epoetin-alfa in hemodialysis patients with anemia.
    Thanakitcharu P; Siriwiwatanakul N
    J Med Assoc Thai; 2007 Dec; 90(12):2574-86. PubMed ID: 18386706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.